Comparative proteomics analysis of differential proteins in respond to doxorubicin resistance in myelogenous leukemia cell lines

Proteome Science

Volumn 13, Issue 1, 2015, Pages

  Qinghong, Shi ^a   Shen, Gao ^a   Lina, Song ^a   Yueming, Zhao ^a,c   Xiaoou, Li ^c   Jianlin, Wu ^d   Chengyan, He ^a   Hongjun, Li ^a   Haifeng, Zhao ^b  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b JIAMUSI UNIVERSITY   (China)

^c The Breast Surgery   (China)

^d MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ENOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; PROTEIN; SORCIN;

ARTICLE; CHEMICAL STRESS; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GLYCOLYSIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; MYELOID LEUKEMIA; PHENOTYPE; PROTEIN EXPRESSION; PROTEOMICS; WESTERN BLOTTING;

EID: 84924591015     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/s12953-014-0057-y     Document Type: Article

References (51)

1. Tacar O, Sriamornsak P, Dass CR. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol. 2013;65(2):157-70.
2. Turkina AG, Baryshnikov AY, Sedyakhina NP, Folomeshkina SV, Sokolova MA, Choroshco ND, et al. Studies of P-glycoprotein in chronic myelogenous leukaemia patients: expression, activity and correlations with CD34 antigen. Br J Haematol. 1996;92(1):88-96.
3. Schisselbauer JC, Silber R, Papadopoulos E, Abrams K, LaCreta FP, Tew KD. Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocyticleukemia patients. Cancer Res. 1990;50(12):3562-8.
4. Takanashi M, Morimoto A, Yagi T, Kuriyama K, Kano G, Imamura T, et al. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia. Haematologica. 2003;88(11):1238-44.
5. Wang Y, Miao H, Li W, Yao J, Sun Y, Li Z, et al. CXCL12/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562/ADM cells. Biochem Pharmacol. 2014;90(3):212-25.
6. Qi J, Liu N, Zhou Y, Tan Y, Cheng Y, Yang C, et al. Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis. Biochem Biophys Res Commun. 2006;349(1):303-9.
7. Yamagishi N, Nakao R, Kondo R, Nishitsuji M, Saito Y, Kuga T, et al. Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein. Biochem Biophys Res Commun. 2014;448(4):430-6.
8. Souza PS, Vasconcelos FC, De Souza Reis FR, Nestal De Moraes G, Maia RC. P-glycoprotein and survivin simultaneously regulate vincristine-induced apoptosis in chronic myeloid leukemia cells. Int J Oncol. 2011;39(4):925-33.
9. Maffei R, Bulgarelli J, Fiorcari S, Martinelli S, Castelli I, Valenti V, et al. Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B Cells through ETA receptor. PLoS One. 2014;9(6):e98818.
10. Liu N, Song W, Wang P, Lee K, Chan W, Chen H, et al. Proteomics analysis of differential expression of cellular proteins in response to avian H9N2 virus infection in human cells. Proteomics. 2008;8(9):1851-8.
11. Li Z, He X, Pan C, Liu N. Mass spectrometric analysis of phosphorylation modification in 14-3-3 epsilon protein. Chinese J Anal Chem. 2013;41(11):1653-8.
12. Liu N, Zhao L, He C, Cai Z. Advances in technologies and biological applications of 18O labeling strategies in LC-MS based proteomics: an updated review. Curr Anal Chem. 2012;8(1):22-34.
13. Li Z, Liu N, Zhang LS, Gong K, Cai Y, Gao W, et al. Proteomic profiling reveals comprehensive insights into adrenergic receptor-mediated hypertrophy in neonatal rat cardiomyocytes. Proteomics Clin Appl. 2009;3(12):1407-21.
14. Liu N, Gong KZ, Cai YB, Li Z. Identification of proteins responding to adrenergic receptor subtype-specific hypertrophy in cardiomyocytes by proteomic approaches. Biochemistry (Mosc). 2011;76(10):1140-6.
15. Hoving S, Gerrits B, Voshol H, Müller D, Roberts RC, van Oostrum J. Preparative two-dimensional gel electrophoresis at alkaline pH using narrow range immobilized pH gradients. Proteomics. 2002;2(2):127-34.
16. Simon WJ, Hall JJ, Suzuki I, Murata N, Slabas AR. Proteomic study of the soluble proteins from the unicellular cyanobacterium Synechocystis sp. PCC6803 using automated matrix-assisted laser desorption/ionization-time of flight peptide mass fingerprinting. Proteomics. 2002;2(12):1735-42.
17. Li RJ, Zhang GS, Chen YH, Zhu JF, Lu QJ, Gong FJ, et al. Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance. Ann Oncol. 2010;21(7):1506-14.
18. Zou L, Wu Y, Pei L, Zhong D, Gen M, Zhao T, et al. Identification of leukemia-associated antigens in chronic myeloid leukemia by proteomic analysis. Leuk Res. 2005;29(12):1387-91.
19. Guillaumond F, Leca J, Olivares O, Lavaut MN, Vidal N, Berthezène P, et al. Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. Proc Natl Acad Sci U S A. 2013;110(10):3919-24.
20. Song S, Finkel T. GAPDH and the search for alternative energy. Nat Cell Biol. 2007;9(8):869-70.
21. Tsutsumi S, Fukasawa T, Yamauchi H, Kato T, Kigure W, Morita H, et al. Phosphoglucose isomerase enhances colorectal cancer metastasis. Int J Oncol. 2009;35(5):1117-21.
22. Tu SH, Chang CC, Chen CS, Tam KW, Wang YJ, Lee CH, et al. Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells. Breast Cancer Res Treat. 2010;121(3):539-53.
23. Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12:152. doi:10.1186/1476-4598-12-152.
24. Granchi C, Minutolo F. Anticancer agents that counteract tumor glycolysis. ChemMedChem. 2012;7(8):1318-50.
25. Yang H, Zhang Q, He J, Lu W. Regulation of calcium signaling in lung cancer. J Thorac Dis. 2010;2(1):52-6.
26. Al-Bahlani S, Fraser M, Wong AY, Sayan BS, Bergeron R, Melino G, et al. P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism. Oncogene. 2011;30(41):4219-30.
27. Colotti G, Poser E, Fiorillo A, Genovese I, Chiarini V, Ilari A. Sorcin, a calcium binding protein involved in the multidrug resistance mechanisms in cancer cells. Molecules. 2014;19(9):13976-89.
28. Padar S, van Breemen C, Thomas DW, Uchizono JA, Livesey JC, Rahimian R. Differential regulation of calcium homeostasis in adenocarcinoma cell line A549 and its Taxol-resistant subclone. Br J Pharmacol. 2004;142(2):305-16.
29. Yang M, Zeng P, Kang R, Yu Y, Yang L, Tang D, et al. S100A8 contributes to drug resistance by promoting autophagy in leukemia cells. PLoS One. 2014;9(5):e97242.
30. Zhao X, Bai Z, Wu P, Zhang Z. S100P enhances the chemosensitivity of human gastric cancer cell lines. Cancer Biomark. 2013;13(1):1-10.
31. McLean WH, Lane EB. Intermediate filaments in disease. Curr Opin Cell Biol. 1995;7(1):118-25.
32. Portet S, Arino O, Vassy J, Schoëvaërt D. Organization of the cytokeratin network in an epithelial cell. J Theor Biol. 2003;223(3):313-33.
33. Snider NT, Weerasinghe SV, Iñiguez-Lluhí JA, Herrmann H, Omary MB. Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation. J Biol Chem. 2011;286(3):2273-84.
34. Pan X, Kane LA, Van Eyk JE, Coulombe PA. Type I keratin 17 protein is phosphorylated on serine 44 by p90 ribosomal protein S6 kinase 1 (RSK1) in a growth- and stress-dependent fashion. J Biol Chem. 2011;286(49):42403-13.
35. Liao J, Ku NO, Omary MB. Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells. J Biol Chem. 1997;272(28):17565-73.
36. He T, Stepulak A, Holmström TH, Omary MB, Eriksson JE. The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase. J Biol Chem. 2002;277(13):10767-74.
37. Belichenko I, Morishima N, Separovic D. Caspase-resistant vimentin suppresses apoptosis after photodynamic treatment with a silicon phthalocyanine in Jurkat cells. Arch Biochem Biophys. 2001;390(1):57-63.
38. Korsching E, Packeisen J, Liedtke C, Hungermann D, Wülfing P, van Diest PJ, et al. The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol. 2005;206(4):451-7.
39. Chen S, Cai J, Zhang W, Zheng X, Hu S, Lu J, et al. Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells. Int J Oncol. 2014;45(1):448-58.
40. Lu WJ, Lee NP, Fatima S, Luk JM. Heat shock proteins in cancer: signaling pathways, tumor markers and molecular targets in liver malignancy. Protein Pept Lett. 2009;16(5):508-16.
41. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci. 2006;31(3):164-72.
42. Venkatakrishnan CD, Dunsmore K, Wong H, Roy S, Sen CK, Wani A, et al. HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2cells: p21 upregulation and G2/M phase cell cycle arrest. Am J Physiol Heart Circ Physiol. 2008;294(4):H1736-44.
43. Sadeh-Mestechkin D, Epstein Shochet G, Pomeranz M, Fishman A, Drucker L, Biron-Shental T, et al. The effect of heat shock protein 27 on extravillous trophoblast differentiation and on eukaryotic translation initiation factor 4E expression. Mol Hum Reprod. 2014;20(5):422-32.
44. Clarke JP, Mearow KM. Cell stress promotes the association of phosphorylated HspB1 with F-actin. PLoS One. 2013;8(7):e68978.
45. Schneider GB, Hamano H, Cooper LF. In vivo evaluation of hsp27 as an inhibitor of actin polymerization: hsp27 limits actin stress fiber and focal adhesion formation afterheat shock. J Cell Physiol. 1998;177(4):575-84.
46. Chae HZ, Kim IH, Kim K, Rhee SG. Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J Biol Chem. 1993;268(22):16815-21.
47. Fisher AB. Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A activities. Antioxid Redox Signal. 2011;15(3):831-44.
48. Su D, Gaffrey MJ, Guo J, Hatchell KE, Chu RK, Clauss TR, et al. Proteomic identification and quantification of S-glutathionylation in mouse macrophages using resin-assisted enrichment and isobaric labeling. Free Radic Biol Med. 2014;67:460-70.
49. Chiang BY, Chou CC, Hsieh FT, Gao S, Lin JC, Lin SH, et al. In vivo tagging and characterization of S-glutathionylated proteins by a chemoenzymatic method. Angew Chem Int Ed Engl. 2012;51(24):5871-5.
50. Sitia R, Molteni SN. Stress, protein (mis)folding, and signaling: the redox connection. Sci STKE. 2004;2004(239):e27.
51. Zhu HJ, Wang JS, Guo QL, Jiang Y, Liu GQ. Reversal of P-glycoprotein mediated multidrug resistance in K562 cell line by a novel synthetic calmodulin inhibitor, E6. Biol Pharm Bull. 2005;28(10):1974-8.